Europe virus filtration market accounted for $696.7 million in 2019 and will grow by 11.34% annually over 2020-2026 owing to the rapid growth of pharmaceutical and biotechnology industry, increasing investments in R&D, surging need for virus removal and clearance amid COVID-19 pandemic.
Highlighted with 35 tables and 46 figures, this 104-page report “Europe Virus Filtration Market 2020-2026 by Product (Consumables, Instruments, Services), Application, End User, and Country: COVID-19 Impact and Growth Opportunity” is based on a holistic research of the entire Europe virus filtration market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2016-2019 and provides forecast from 2020 till 2026 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe virus filtration market in every aspect of the classification from perspectives of Product, Application, End User, and Country.
Based on Product, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.
Consumables
Instruments
• Filtration Systems
• Chromatography systems
Services
Based on Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.
Biological Applications
• Vaccines and Therapeutics
• Blood and Blood Products
• Cellular and Gene Therapy Products
• Tissue and Tissue Products
• Stem Cell Products
Medical Devices
Water Purification
Air Purification
Other Applications
Based on End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.
• Pharmaceutical and Biotechnology Companies
• Contract Research Organisations (CROs)
• Academic & Research Institutes
• Medical Device Companies
• Other End Users
Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2016-2026. The breakdown of key national markets by Product, Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Europe virus filtration market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Asahi Kasei Medical Co., Ltd.
Charles River Laboratories International, Inc.
Clean Cells
General Electric Company
Lonza Group AG
Merck KGaA
MilliporeSigma
Pall Corporation
Sartorius AG
Thermo Fisher Scientific, Inc.
Wuxi Apptec
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents
1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 18
2.1 Market Size and Forecast 18
2.1.1 Impact of COVID-19 on World Economy 19
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 27
2.4 Emerging Opportunities and Market Trends 30
2.5 Porter’s Fiver Forces Analysis 34
3 Segmentation of Europe Market by Product 38
3.1 Market Overview by Product 38
3.2 Consumables 40
3.3 Instruments 41
3.3.1 Filtration Systems 42
3.3.2 Chromatography systems 43
3.4 Services 44
4 Segmentation of Europe Market by Application 45
4.1 Market Overview by Application 45
4.2 Biological Applications 47
4.2.1 Vaccines and Therapeutics 49
4.2.2 Blood and Blood Products 50
4.2.3 Cellular and Gene Therapy Products 51
4.2.4 Tissue and Tissue Products 52
4.2.5 Stem Cell Products 53
4.3 Medical Devices 54
4.4 Water Purification 55
4.5 Air Purification 56
4.6 Other Applications 57
5 Segmentation of Europe Market by End User 58
5.1 Market Overview by End User 58
5.2 Pharmaceutical and Biotechnology Companies 60
5.3 Contract Research Organisations (CROs) 61
5.4 Academic & Research Institutes 62
5.5 Medical Device Companies 63
5.6 Other End Users 64
6 European Market 2019-2026 by Country 65
6.1 Overview of European Market 65
6.2 UK 68
6.3 France 70
6.4 Germany 72
6.5 Spain 74
6.6 Italy 76
6.7 Russia 78
6.8 Rest of European Market 80
7 Competitive Landscape 82
7.1 Overview of Key Vendors 82
7.2 New Product Launch, Partnership, Investment, and M&A 85
7.3 Company Profiles 86
Asahi Kasei Medical Co., Ltd. 86
Charles River Laboratories International, Inc. 88
Clean Cells 89
General Electric Company 90
Lonza Group AG 91
Merck KGaA 92
MilliporeSigma 93
Pall Corporation 94
Sartorius AG 95
Thermo Fisher Scientific, Inc. 96
Wuxi Apptec 97
8 Investing in Europe Market: Risk Assessment and Management 98
8.1 Risk Evaluation of Europe Market 98
8.2 Critical Success Factors (CSFs) 101
Related Reports and Products 104
Key Players (this may not be a complete list and extra companies can be added upon request):
Asahi Kasei Medical Co., Ltd.
Charles River Laboratories International, Inc.
Clean Cells
General Electric Company
Lonza Group AG
Merck KGaA
MilliporeSigma
Pall Corporation
Sartorius AG
Thermo Fisher Scientific, Inc.
Wuxi Apptec
Ěý
Ěý
*If Applicable.
